8x8 and Aryaka Partner to Enhance Cloud Communications for Global Enterprises
Strategic Alliance will improve communications experience for business users worldwide
SAN MATEO, Calif., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Aryaka®, the leading global SD-WAN provider, and 8x8, Inc. (NASDAQ:EGHT), the world's first Communications Cloud provider, today announced that they are entering a strategic partnership that will improve the performance and reliability of business-critical cloud unified communications. This will enable global mid-market and enterprise companies to enhance business communications, collaboration and customer engagement for their employees, customers and partners around the world.
Through this partnership, Aryaka's global SD-WAN solution will provide enterprise-grade private connectivity to further enhance the superior voice and video quality delivered by the 8x8 Communications Cloud(TM). When tested against several leading Unified Communications as a Service (UCaaS) providers, 8x8 was recently found by the Tolly Group to deliver the highest voice quality across multiple client platforms and network impairment conditions. 8x8 was also recently named a Leader in the 2017 Gartner Magic Quadrant for Unified Communications as a Service, Worldwide 1 for the sixth year in a row.
When 8x8 and Aryaka are deployed together, enterprise voice and video traffic is routed through Aryaka's global private network instead of over the public Internet, thereby minimizing latencies, packet loss and jitter. As a result, organizations will benefit from increased employee productivity by reducing service interruptions and dropped calls.
"Our partnership with 8x8 enables enterprises to significantly enhance the performance of their voice and video communications globally regardless of changing network conditions," said Shawn Farshchi, President and CEO of Aryaka. "This improves business execution and delivers the stable and high-quality experiences that employees, partners, and customers demand from communications, collaboration and customer engagement operations."
"8x8 is committed to providing mid-market and enterprise companies with the highest levels of quality and reliability for cloud communications, collaboration and contact center services while simplifying service deployment and reducing costs," said Mehdi Salour, Senior Vice President of Global Network and DevOps at 8x8. "The Aryaka partnership will enable us to further improve quality of service for voice, video and web conferencing, delivering a superior end-user experience for employees, partners and customers around the world, even in the face of adverse customer network conditions."
Platform Specialty Products (PSP), a global, diversified producer of high technology specialty chemical products, has deployed 8x8-over-Aryaka to improve its UCaaS operations and provide high-quality communications and collaboration to its employees.
"Prior to deploying 8x8 and Aryaka, our remote locations were experiencing WAN performance issues, which resulted in dropped calls when attempting to connect to other offices around the world," said Dustin Collins, Vice President of Global Infrastructure Services at PSP. "Post deployment, not only do we no longer drop calls, but voice quality has improved immensely. Our team is more productive as a result. With such a noticeable improvement in network and communications quality, we're looking to implement the solution in several locations in Latin America and Asia."
The 8x8 Communications Cloud combines unified communications (8x8 Virtual Office), team collaboration interoperability (8x8 Sameroom(TM)), contact center (8x8 Virtual Contact Center and 8x8 ContactNow(TM)) and real-time analytics in a single open platform that integrates across clouds, applications and devices, eliminating information silos to expose vital, real-time intelligence.
About 8x8, Inc.
8x8, Inc. (NASDAQ:EGHT) is the provider of the world's first Communications Cloud that combines unified communications, team collaboration, contact center, and analytics in a single, open and real-time platform. 8x8 eliminates information silos to expose vital, real-time intelligence across multiple clouds, applications and devices to improve individual and team productivity, business performance and customer experience. For additional information, visit www.8x8.com, or connect with 8x8 on LinkedIn, Twitter, Google+ and Facebook.
Aryaka is transforming how global enterprises connect sites and users worldwide, and use mission-critical applications to support modern business execution demands. Aryaka's Global SD-WAN combines a purpose-built private network, SD-WAN, optimization and acceleration techniques, connectivity to cloud platforms, and network visibility in a single solution that is delivered as a service. To learn more, visit www.aryaka.com. Follow us on Twitter, Facebook, YouTube and LinkedIn.
 Gartner "Magic Quadrant for Unified Communications as a Service, Worldwide" by Daniel O'Connell, Bern Elliot, Rafael A Benitez, September 6, 2017.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
This press release includes links to content published by third parties. 8x8 was not involved in the preparation of this content and has not independently verified its accuracy.
8x8®, 8x8 Virtual Office®, 8x8 Virtual Contact Center®, 8x8 Sameroom(TM), and 8x8 Communications Cloud(TM) are trademarks of 8x8, Inc. Aryaka® is a trademark of Aryaka Networks, Inc.
8x8 Media Contact
John Sun, 408-692-7054
InkHouse for 8x8
Brittany Hendrickson, 415-299-6370
Aryaka Media Contact
Director of Marketing
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aryaka via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
Real People Investment Holdings Limited - Outcome of Written Procedure for Nordic Bonds21.11.2017 06:22 | Pressemelding
Real People Investment Holdings Limited up to SEK 260,000,000 and up to NOK 135,000,000 Senior Unsecured Callable Bonds 2013/2018 ISIN: SE 000 5392560 and NO 001 0689342 Johannesburg, 20 November 2017 The Nordic bondholders have approved Real People Investment Holdings Limited's (the "Company" or RPIH") proposal for restructure of the Company's debt liabilities and amendments to the terms and conditions for the bonds. Terms defined in the terms and conditions of the abovementioned bond issue (the "Terms and Conditions") shall have the same meaning when used in this notice, unless otherwise defined herein. Results from written procedure On 10 November 2017, a notice of written procedure was sent to the Bondholders, in which the Company requested that holders of its NOK Bonds and its SEK Bonds approve a restructure of the Company's debt liabilities (the "Notice"). The voting
TESARO Announces European Commission Approval of ZEJULA® for Women With Recurrent Ovarian Cancer20.11.2017 13:00 | Pressemelding
ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian cancer, regardless of BRCA mutation or biomarker status Approval supported by robust data from a randomized, well-controlled Phase 3 trial Only PARPi to offer once-daily, oral dosing to enable convenient administration for maintenance treatment First commercial launches planned for Germany and the UK this December ZUG, Switzerland, Nov. 20, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology focused biopharmaceutical company, announced today that the European Commission (EC) has granted marketing authorization for ZEJULA® (niraparib) as a monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete response (CR) or partial response (PR) to platinum-based chemotherapy. ZEJULA is the first once-daily, oral poly (
PledPharma and Solasia enter license agreement to develop and commercialize PledOx® in Asia20.11.2017 07:30 | Pressemelding
Stockholm, 2017-11-20 07:30 CET (GLOBE NEWSWIRE) -- Stockholm, Sweden / Tokyo, Japan, November 20th 2017 - PledPharma AB (“PledPharma”) (STO: PLED) and Solasia Pharma K.K. (“Solasia”) (TSE: 4597) today jointly announce that they have entered a license agreement pertaining to the clinical development and commercialization of PledOx® in Japan, China, Hong Kong, Macau, South Korea and Taiwan. Under the terms of this agreement, PledPharma grants exclusive development and commercialization rights to PledOx® in the territories mentioned and Solasia will pay upfront, development, regulatory and sales milestones of up to ~USD 83 million (SEK 700 million)*. In addition, Solasia will pay industry standard royalty rates on sales applicable for a deal pertaining to an in-licensed asset in Phase III development. Solasia will also fully finance an expansion of the Phase III program to include Asian patients subject to regulatory consultations. The license agreement is initially focused on th
CrownBio Launches an Innovative Grant Program to Fund Advancements in Preclinical Oncology Research17.11.2017 18:07 | Pressemelding
SANTA CLARA, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the launch of a grant program supporting oncology research scientists which provides funding for projects that show promise for scientific advancement of Patient Derived Xenograft (PDX) technology. Research Grants up to $50,000 will be awarded to projects focused on accelerating the pace of preclinical innovation and novel PDX methodologies that improve clinical predictions with sound science. The program offers an opportunity for investigators to receive funding for projects that may not receive support through traditional funding channels. Submitted proposals will be reviewed and selected by CrownBio's Scientific Steering Committee with the goa
Barings Backs Sentinel Capital Partners in Acquisition of Nekoosa17.11.2017 17:00 | Pressemelding
CHARLOTTE, N.C., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Barings, one of the world's leading asset management firms, announced today that it served as Lead Agent on a senior secured credit facility to support Sentinel Capital Partners in its acquisition of Nekoosa ("Nekoosa" or the "Company"). Headquartered in Nekoosa, Wisconsin, the Company is a leading manufacturer of specialty paper and film products used in the graphics and commercial print markets, including application and pressure-sensitive tapes, specialty synthetic papers, sheeted digital and offset grade carbonless paper, and extruded film products. Nekoosa serves a highly diverse base of more than 70,000 commercial print and graphics shops in 65 countries. Barings served as lead senior lender on the transaction, which included a senior term loan and a revolving credit facility. "Sentinel is pleased to have Barings' support on our investment in Nekoosa," said Scott Perry, a partner with Sentinel Capital Partner
At SC17, ExaScaler and PEZY Computing Unveil Gyoukou Supercomputer with a High Combined Green500/Top500 Ranking16.11.2017 23:29 | Pressemelding
ExaScaler and PEZY Computing Also Take Top Three Green500 Positions DENVER, Nov. 16, 2017 (GLOBE NEWSWIRE) -- At SC17, ExaScaler and PEZY Computing unveiled their Gyoukou supercomputer whose Green500 and Top500 rankings attest to a unique combination of high efficiency and computing power. The Gyoukou supercomputer is installed at the Yokohama Research Institute in Japan. (Video: PEZY Liquid immersion cooling) PEZY supercomputers leverage 48V Factorized Power, a high efficiency, high density power distribution architecture. PEZY's CPUs are co-packaged with Vicor's Power-on-Package ("PoP") Modular Current Multipliers ("MCMs"), which enable efficient, direct 48V to sub-1V current multiplication at the XPU. ExaScaler and PEZY Computing also achieved the #1, #2 and #3 positions on the Green500. These supercomputer system installations also utilize 48V Factorized Power. Come see us at SC17 at Booth 633 where ExaScaler / PEZY Computing will be
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom